CapLaw-2024-06

  • Kinarus Therapeutics Holding AG in Liquidation reverse takeover (RTO) transaction with Curatis AG

    On 29 January 2024, Kinarus Therapeutics Holding AG in liquidation (Kinarus) announced that it has entered into a transaction agreement (Transaction Agreement) with Curatis AG (Curatis) regarding a contemplated combination transaction. Curatis is a privately owned specialty pharmaceutical company focusing predominantly on orphan/ultra-orphan diseases and specialty care diseases. Under the terms of the Transaction Agreement,…

    By

    CapLaw

    Reference:
    Read more: Kinarus Therapeutics Holding AG in Liquidation reverse takeover (RTO) transaction with Curatis AG